Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro

Said, 1988, Vasoactive intestinal peptide in the lung, Ann. N.Y. Acad. Sci., 527, 450, 10.1111/j.1749-6632.1988.tb26999.x Dey, 1981, Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cats, and human subjects, Cell. Tissue Res., 220, 231, 10.1007/BF00210505 Foda, 1988, Vasoactive intestinal peptide protects against HCL-induced pulmonary edema in rats, Ann. N.Y. Acad. Sci., 527, 633, 10.1111/j.1749-6632.1988.tb27027.x Pakbaz, 1988, Vasoactive intestinal peptide (VIP) as a modulator of PAF-induced lung injury, Clin. Res., 36, 626A Berisha, 1990, Vasoactive intestinal peptide prevents lung injury due to xanthine/xanthine oxidase, Am. J. Physiol., 259, L151 Guerrero, 1981, Interaction of vasoactive intestinal peptide with human blood mononuclear cells, Mol. Cell. Endocrinol., 21, 151, 10.1016/0303-7207(81)90052-6 Ottaway, 1983, Specific binding of VIP to human circulating mononuclear cells, Can. J. Physiol. Pharmacol., 61, 664, 10.1139/y83-103 Wiik, 1985, Binding of vasoactive intestinal polypeptide (VIP) by human blood monocytes: demonstration of specific binding sites, Regul. Pept., 12, 145, 10.1016/0167-0115(85)90195-8 Danek, 1983, Specific binding sites for vasoactive polypeptide on nonadherent peripheral blood lymphocytes, J. Immunol., 131, 1173 Ottaway, 1984, Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses, J. Immunol., 132, 417 Sakakibara, 1990, Binding of vasoactive intestinal polypeptide (VIP) to rat alveolar macrophages: demonstration of specific binding sites coupled to adenylate cyclase, Am. Rev. Resp. Dis., 141, A645 Cutz, 1978, Release of vasoactive intestinal polypeptide in mast cells by histamine liberators, Nature, 275, 661, 10.1038/275661a0 O'Dorisio, 1980, Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes, J. Lab. Clin. Med., 96, 666 Cox, 1984, VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF), Peptides, 5, 325, 10.1016/0196-9781(84)90228-6 Ercal, 1988, Vasoactive intestinal peptide receptors in human platelet membrane: characterization of binding and functional assay, Ann. N.Y. Acad. Sci., 527, 663, 10.1111/j.1749-6632.1988.tb27036.x Aliakbari, 1987, Selective localization of vasoactive intestinal peptide and substance P in human eosinophils, Biochem. Biophys. Res. Commun., 148, 1440, 10.1016/S0006-291X(87)80293-0 Ottaway, 1987, Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells, Immunology, 62, 291 Peuriere, 1990, Dual effect of vasoactive intestinal peptide on the mitogenic response of rabbit spleen lymphocytes, Regul. Pept., 27, 117, 10.1016/0167-0115(90)90210-N Boudard, 1991, Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis, J. Neurosci. Res., 29, 29, 10.1002/jnr.490290104 Stanisz, 1986, Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes and spleen, J. Immunol., 136, 152 Ottaway, 1984, In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells, J. Exp. Med., 160, 1054, 10.1084/jem.160.4.1054 Rola-Pleszczynski, 1985, The effects of vasoactive intestinal peptide on human natural killer cell function, J. Immunol., 135, 2569 Moore, 1988, Depression of lymphocyte traffic in sheep by vasoactive intestinal peptide (VIP), Immunology, 64, 1 Sibille, 1990, Macrophages and polymorphonuclear neutrophils in lung defense and injury, Am. Rev. Resp. Dis., 141, 471, 10.1164/ajrccm/141.2.471 Bar-Shavit, 1984, Enhancement of phagocytosis — a newly found activity of substance P residing in its N-terminal tetrapeptide sequence, Biochem. Biophys. Res. Commun., 94, 1445, 10.1016/0006-291X(80)90581-1 Hartung, 1983, Activation of macrophages by substance P: induction of oxidative burst and thromboxane release, Eur. J. Pharm., 89, 301, 10.1016/0014-2999(83)90511-3 Wiik, 1989, Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism, Regul. Pept., 25, 187, 10.1016/0167-0115(89)90260-7 Segura, 1991, Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages, Regul. Pept., 33, 133, 10.1016/0167-0115(91)90208-X Bar-Shavit, 1982, Neurotensin-macrophage interaction: specific binding and augmentation of phagocytosis, Neuropeptides, 2, 325, 10.1016/0143-4179(82)90070-1 Lotz, 1988, Effect of neuropeptides on production of inflammatory cytokines by human monocytes, Science, 241, 1218, 10.1126/science.2457950 Sakakibara, 1990, Vasoactive intestinal polypeptide (VIP) inhibits superoxide anion release from rat alveolar macrophages, Am. Rev. Resp. Dis., 141, A645 Gardner, 1973, Technique for differentiating particles that are cell-associated or ingested by macrophages, Appl. Microbiol., 25, 471, 10.1128/AEM.25.3.471-475.1973 Falk, 1980, A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration, J. Immunol. Methods, 33, 239, 10.1016/S0022-1759(80)80014-7 Dauber, 1978, Chemotactic activity of guinea pig alveolar macrophages, Am. Rev. Resp. Dis., 117, 673 Remington, 1970, The analysis of variance, 283 Winer, 1971, Fisher's paired least significance difference, 120 Remington, 1971, Chi-square tests for frequency data, 229 Said, 1990, Neuropeptides as modulators of injury and inflammation, Life Sci., 47, 19, 10.1016/0024-3205(90)90580-K O'Dorisio, 1981, Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase, J. Immunol., 127, 2551 Cox, 1973, The depression of phagocytosis by exogenous cyclic nucleotides, prostaglandins and theophylline, J. Cell Biol., 59, 480, 10.1083/jcb.59.2.480 Weissmann, 1975, Reciprocal effects of cAMP and cGMP on microtubule-dependent release of lysosomal enzymes, Ann. N.Y. Acad. Sci., 253, 750, 10.1111/j.1749-6632.1975.tb19243.x Hatch, 1977, Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic modulators, J. Immunol., 119, 450 Rivkin, 1975, The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils, J. Immunol., 115, 1126 Hill, 1978, Cyclic nucleotides as modulators of leukocyte chemotaxis, 179